Remote Ischemic Conditioning Using the autoRIC
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.
Also called NCT03318575
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 500 participants
- Sponsor
- CellAegis US, Inc.
- Registry
-
NCT03318575
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Unknown status
Technical summary
Registry record NCT03318575. Randomized; single masking; primary purpose prevention. Start 2018-01-30 (actual); primary completion 2019-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Remote Ischemic Conditioning Using the autoRIC
- Acronym
- SHIELD
- Condition
- Ischemia-Reperfusion Injury
- Intervention (Device)
- autoRIC
- Intervention (Device)
- autoRIC Sham
- Lead sponsor
- CellAegis US, Inc.
Record details
- Record id
cardio:ct-nct03318575- Content hash
2bbba4e2db81bbe401149b95bb5ea3d3593bdfed3a8be852d29d9738b72c7f68